Betts GJ - Search Results

1

Analysis of the T-cell receptor repertoires of tumor-infiltrating conventional and regulatory T cells reveals no evidence for conversion in carcinogen-induced tumors.

Hindley JP, Ferreira C, Jones E, Lauder SN, Ladell K, Wynn KK, Betts GJ, Singh Y, Price DA, Godkin AJ, Dyson J, Gallimore A. Hindley JP, et al. Among authors: betts gj. Cancer Res. 2011 Feb 1;71(3):736-46. doi: 10.1158/0008-5472.CAN-10-1797. Epub 2010 Dec 13. Cancer Res. 2011. PMID: 21156649 Free PMC article.

2

The impact of regulatory T cells on carcinogen-induced sarcogenesis.

Betts G, Twohig J, Van den Broek M, Sierro S, Godkin A, Gallimore A. Betts G, et al. Br J Cancer. 2007 Jun 18;96(12):1849-54. doi: 10.1038/sj.bjc.6603824. Epub 2007 Jun 12. Br J Cancer. 2007. PMID: 17565340 Free PMC article.

3

Regulatory T cells inhibit Fas ligand-induced innate and adaptive tumour immunity.

Simon AK, Jones E, Richards H, Wright K, Betts G, Godkin A, Screaton G, Gallimore A. Simon AK, et al. Eur J Immunol. 2007 Mar;37(3):758-67. doi: 10.1002/eji.200636593. Eur J Immunol. 2007. PMID: 17294404 Free PMC article.

4

Suppression of tumour-specific CD4⁺ T cells by regulatory T cells is associated with progression of human colorectal cancer.

Betts G, Jones E, Junaid S, El-Shanawany T, Scurr M, Mizen P, Kumar M, Jones S, Rees B, Williams G, Gallimore A, Godkin A. Betts G, et al. Gut. 2012 Aug;61(8):1163-71. doi: 10.1136/gutjnl-2011-300970. Epub 2011 Dec 29. Gut. 2012. PMID: 22207629 Free PMC article.

5

Regulating the immune response to tumours.

Betts GJ, Clarke SL, Richards HE, Godkin AJ, Gallimore AM. Betts GJ, et al. Adv Drug Deliv Rev. 2006 Oct 1;58(8):948-61. doi: 10.1016/j.addr.2006.05.006. Epub 2006 Aug 17. Adv Drug Deliv Rev. 2006. PMID: 17070961 Review.

6

CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer.

Clarke SL, Betts GJ, Plant A, Wright KL, El-Shanawany TM, Harrop R, Torkington J, Rees BI, Williams GT, Gallimore AM, Godkin AJ. Clarke SL, et al. Among authors: betts gj. PLoS One. 2006 Dec 27;1(1):e129. doi: 10.1371/journal.pone.0000129. PLoS One. 2006. PMID: 17205133 Free PMC article.

7

CD59 blockade enhances antigen-specific CD4+ T cell responses in humans: a new target for cancer immunotherapy?

Sivasankar B, Longhi MP, Gallagher KM, Betts GJ, Morgan BP, Godkin AJ, Gallimore AM. Sivasankar B, et al. Among authors: betts gj. J Immunol. 2009 May 1;182(9):5203-7. doi: 10.4049/jimmunol.0804243. J Immunol. 2009. PMID: 19380765 Free PMC article.

8

Assessing the prognostic value of preoperative carcinoembryonic antigen-specific T-cell responses in colorectal cancer.

Scurr MJ, Brown CM, Costa Bento DF, Betts GJ, Rees BI, Hills RK, Gallimore A, Godkin A. Scurr MJ, et al. Among authors: betts gj. J Natl Cancer Inst. 2015 Feb 9;107(4):djv001. doi: 10.1093/jnci/djv001. Print 2015 Apr. J Natl Cancer Inst. 2015. PMID: 25669203 Free PMC article.

9

Expansion of hepatitis C-specific CD4+CD25+ regulatory T cells after viral clearance: a mechanism to limit collateral damage?

Godkin A, Ng WF, Gallagher K, Betts G, Thomas HC, Lechler RI. Godkin A, et al. J Allergy Clin Immunol. 2008 May;121(5):1277-1284.e3. doi: 10.1016/j.jaci.2008.01.070. Epub 2008 Mar 19. J Allergy Clin Immunol. 2008. PMID: 18355912

10

Transiently Activated Human Regulatory T Cells Upregulate BCL-XL Expression and Acquire a Functional Advantage in vivo.

Issa F, Milward K, Goto R, Betts G, Wood KJ, Hester J. Issa F, et al. Front Immunol. 2019 Apr 24;10:889. doi: 10.3389/fimmu.2019.00889. eCollection 2019. Front Immunol. 2019. PMID: 31068951 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters